Skip to content

Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission

A Cluster-randomized Controlled Trial of Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01764282
Enrollment
11096
Registered
2013-01-09
Start date
2012-01-01
Completion date
2015-12-31
Last updated
2017-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

HIV, serodiscordant couples HIV sero-conversion, anti-retroviral therapy, intervention

Brief summary

The purpose of this study is to evaluate the effectiveness of reducing HIV transmission among sero-discordant couples by applying comprehensive intervention components.

Detailed description

A cluster-randomized controlled trial was carried out in forty counties from 16 cities. The strategy of Social Marketing was applied to influence sero-discordant couples' behavioral changes including safer sexual intercourses, regular HIV testing for the negative partners, antiretroviral therapy initiation.

Interventions

BEHAVIORALcomprehensive intervention components

ART promotion, Couple testing and consulting promotion, and Condom use promotion

Sponsors

National Center for AIDS/STD Control and Prevention, China CDC
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 59 Years
Healthy volunteers
No

Inclusion criteria

* Couples are required to have a stable relationship and live together in the last 3 months; * Older than 18 years and younger than 60 years; without regard to CD4 count; * Open cohort(any newly diagnosed serodiscordant couples who are eligible for treatment will be included during the study period).

Exclusion criteria

* Couples are not have a stable relationship or do not live together in the last 3 months; * Younger than 18 years old.

Design outcomes

Primary

MeasureTime frame
HIV seroconversion rate of HIV negatives among HIV serodiscordant couplesup to 2 years

Secondary

MeasureTime frame
Proportion of HIV positives receiving ART among HIV serodiscordant couplesup to 2 years
The incidence rate of AIDS-related diseases of HIV positives among serodiscordant couplesup to 2 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026